The Bell2Bell (B2B) Podcast

Bell2Bell’s latest podcast features Dr. Marshal Lemerani, Program Manager for the Malawi Ministry of Health and Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a biopharmaceutical company dedicated to advancing treatments for neurological disorders, which takes center stage in the episode. During this insightful conversation, Howard Weisman, CEO of PaxMedica, and Dr. Marshal Lemerani, Program Manager at the Malawi Ministry of Health, joined host Stuart Smith to discuss the urgent request for medical assistance from Malawi and PaxMedica's swift response.

The podcast sheds light on PaxMedica's commitment to addressing the critical shortage of medications required to combat the life-threatening sleeping sickness crisis in Malawi. Weisman highlights the pressing need for IV suramin (PAX-101), a crucial medication in treating Trypanosoma brucei rhodesiense Human African trypanosomiasis (TBr HAT), and PaxMedica's immediate action plan to aid. Lemerani shares insights into the challenges faced by healthcare professionals in Malawi and expresses gratitude for PaxMedica's support in this dire situation.

To listen to the full podcast and learn more about PaxMedica's response to the urgent medical situation in Malawi, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.